Adherence Solutions

A Better Patient Experience

Supporting patients with product & disease state education.

Empowering Patient Engagement

The patient’s commitment to adhering to their prescribed therapy regimen plays a pivotal role in their overall outcome. Patient loyalty significantly contributes to building strong brand recognition. UBC’s approach to creating a patient adherence model considers the individual, their beliefs, behaviors, the complexity of the prescribed product, and its administration method. Our comprehensive patient adherence services also incorporate data analytics to further enhance patient support.

Technology-Enabled Patient Adherence Solutions

Patient adherence services are important not only for patient engagement but to also establish brand loyalty. UBC’s experience in delivering long-term, sustained patient adherence solutions is an invaluable resource for customers. By combining exceptional care models, foundational techniques proven to foster persistence, and technology-enabled solutions UBC can improve adherence and generate widespread, positive effects on patient trust and, ultimately, your brand.

Comprehensive Patient Care

By coordinating exceptional and compassionate care, UBC partners with patients throughout their healthcare journey to eliminate barriers to care. From start to finish, our specialized networks and clinical care teams support the patient every step of the way.

Specialized Networks

UBC’s nationwide network of credentialed home health care agencies and retail pharmacies offer expertise in a wide variety of therapeutic areas. Our network ensures your patients can access care when and where they prefer.

Cluster/heat map of the USA showing where Patients have the most access to UBC's network of home care agents.
Home care locations
0
In-home visits conducted annually
0 +
Trained clinician in reasonable driving distance of 90% of US population
0 % Coverage
Two businesswomen speak at a conference room table as one woman holds a tablet for discussion.

Clinical Education

UBC’s clinical care teams work closely with our customers and patients to deliver comprehensive patient adherence and education programs across most therapeutic areas with expertise in complex, rare, cell and gene, and specialty therapies.

Explore Expert Adherence Insights

Frequently Asked Questions

What does UBC's adherence model actually do?

The model combines nurse-led patient engagement, technology-enabled workflows, education across the patient and caregiver, and ongoing monitoring of adherence risk. Patients are supported by clinical staff trained on the specific therapy, with cadences and content tailored to the disease and the individual — not generic reminders.

UBC operates a nationwide network of credentialed home health care agencies and retail pharmacies, with a trained clinician within reasonable driving distance of approximately 90% of the US population. Nurses complete programme-specific training including competency testing before being deployed to a patient, and the network is matched to therapeutic area requirements — cell and gene therapies are not staffed the same way oncology adherence programmes are.

Stratified engagement models — high, medium, and low risk — determine cadence and intensity, with risk informed by the therapy, the disease, and the patient’s circumstances. Clinical teams build relationship-based engagement that takes the whole patient into account, including caregiver and household context. The starting point is that adherence is earned through trust, not driven by reminders.

Beyond persistence and discontinuation rates, the team tracks reasons for discontinuation, side-effect-driven non-adherence, and risk signals that emerge in nurse interactions. Real-world data linkage — through partners like Datavant — extends visibility beyond what the programme alone captures, showing whether patients are still on therapy across the wider healthcare encounters they have.

Nurses provide disease, device, and usage instruction in-person and virtually, take inbound calls from patients, caregivers, and prescribers, and oversee adverse event reporting and product quality complaints in line with regulatory and manufacturer requirements. The clinical depth means they can pick up early signs of trouble — a side effect that hasn’t been mentioned to the physician, an injection technique that isn’t quite right — rather than only handling scheduled check-ins.

Cell and gene therapy adherence has distinct demands: complex dosing, site-of-care coordination, infusion protocol education, and patient and caregiver support through both the treatment window and longer-term monitoring. UBC’s clinical teams have therapeutic experience in these areas, with networks and protocols designed for high-touch, low-volume specialty populations rather than generic chronic-disease support.

Automated workflows handle reminders, scheduled outreach, and care coordination; SMS and virtual assistants handle education and feedback; and dashboards give programme managers visibility into adherence patterns and at-risk patients. The technology is meant to free the clinical team to spend time where it matters, not replace them.

Learn More About UBC's Adherence Solutions

Interested in learning more about how UBC’s adherence solutions can help build trust, drive patient adherence, and enable the success of your therapy?

UBC logo white

Thank You for Connecting with UBC

.

 

What You Can Expect Next

.

UBC logo white

Get Ready to Change Your Business

.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.